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ABSTRACT 
 
 
Cancer is one of the leading causes of death worldwide and radiation therapy is 
used as a treatment method on millions of patients each year. While the biological 
response of tendon tissue to high-dose radiation has been investigated over the years, the 
effects of low-dose gamma radiation on tendons is not well understood. The goal of this 
research is to investigate the impact of clinically relevant low dose gamma radiation on 
tendon tissue. 
Fresh tendons were harvested from mature porcine forefeet and exposed to 5 Gray 
of Cesium gamma radiation. Histological and chemical data were obtained over the 
course of five days following irradiation.  
In the first phase of the study, histological aspects of the tendon were examined. 
Masson’s Trichrome revealed an increased expression of collagen while H&E and 
Safranin-O found an increased occurrence of apoptosis, which was confirmed by DNA 
fragment end labeling.  
The second phase of the study investigated the sGAG content of the tissue and 
culture media over time following irradiation exposure. Significant differences were seen 
between the control and irradiated groups in the sGAG content within the tissue (on days 
3 and 5) and in the culture media (on day 5).  
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CHAPTER ONE 
INTRODUCTION 
1.1 Motivation 
Connective tissues such as tendon or cartilage were once thought to be impervious 
to the damaging effects of ionizing radiation. However, over the last few decades, 
researchers have discovered that this isn’t always the case. The majority of available 
literature combining the study of radiation and tendons focuses on very high levels of 
radiation (Mrad) and its impact on massively dense tendons (e.g. rat or kangaroo tail). 
            Due to the increasing prevalence of cancer and the increasing use of radiotherapy 
to treat it, it is important to investigate the impact of clinically relevant (low-dose) 
ionizing radiation on tendons. This research is significant because it will allow us to see if 
extra precautions should be taken to protect tendons or ligaments in the immediate 
vicinity of a joint, bone, or muscle receiving radiation treatment. 
1.2  Research Aims 
In this study, we will first investigate the microscopic histological changes caused 
by 5 Gray (Gy) of gamma radiation. We will look for evidence of an increase in the 
occurrence of apoptosis in irradiated tissue, investigate levels of collagen synthesis, study 
the proteoglycan expression in the tissue, and examine the tissue samples for evidence of 
calcification following irradiation. In the next phase of this study, biochemical assays will 
be employed to look at apoptosis and the levels of sulfated glycosaminoglycans (sGAGs) 
in the tissue and culture media. 
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CHAPTER TWO 
LITERATURE REVIEW: TENDONS 
 
2.1  Introduction to Tendons 
Tendons are part of the musculoskeletal system and serve to bridge the connection 
between muscles and the bones they operate. Tendons are able to transmit the forces 
generated by the muscles to their respective 
bones, allowing for joint movement. Under 
normal loads, tendons maintain smooth joint 
movement and mechanics throughout their 
range of motion (Lin, Cardenas, & Soslowsky, 
2004). When presented with higher loads, 
tendons limit the range of motion to anatomical 
barriers (O’Brien, 1992; Lin et al., 2004). 
Because of this, tendons not only aid in 
locomotion but also help to support joints and 
prevent injury (Lin et al., 2004). Tendons are a 
type of soft connective tissue called dense 
fibrous connective tissue or dense regular 
connective tissue.  
Dense regular connective tissue consists of closely packed collagen fibers, 
arranged in bundles, and oriented parallel to each other (Saladin, 2012). The parallel fiber 
arrangement occurs as an adaptation to the directions of stresses in musculoskeletal 
Figure 2.1: Dense regular connective tissue 
of a tendon (400x) (Saladin, 2012) 
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tissues (Saladin, 2012). In dense regular connective tissue, the only cell types present 
under normal physiological conditions are specialized types of fibroblast, called 
tenoblasts and tenocytes (Kannus, 2000). However, under pathological conditions, other 
cell types infiltrate into tendon tissue, including inflammatory cells, macrophages, and/or 
myofibroblasts (Kannus, 2000). Tenoblasts are large, slender cells that, during tendon 
metabolism, are capable of producing all of the components that make up the tendon 
matrix (Kannus, 2000; Saladin, 2012) (Figure 2.1). The highly proliferative tenoblasts 
range in length between 20 and 70 µm and vary in width from 8 to 20 µm. Tenocytes, 
which are terminally differentiated cells, ranges from 80 to 300 µm in diameter and they 
have longer cellular processes (Kannus, 2000; Franchi, Trirè, Wuaranta, Orsini, & Ottani, 
2007a). Tenoblast presence decreases with age as they tend to become quiescent 
tenocytes. 
In tissue sections, there appears to be a vacant space amid the cells and fibers, as 
seen in Figure 2.1. This empty space is occupied by the ground substance, a featureless, 
gelatinous substance arising from three classes of large molecules: glycosaminoglycans 
(GAGs), proteoglycans (PGs), and glycoproteins (Kannus, 2000; Saladin, 2012). This 
substance serves to protect the fragile cells from mechanical injury by absorbing 
compressive forces.  
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2.1.1  Hierarchical Structure 
 The basic building block of all soft connective tissue is the collagen fibril. In 
order for connective tissues to form their unique functions, fibrils are arranged in a 
particular architecture. The hierarchical structure of connective tissue reflects and 
depends on different stress states under which the tissue is required to function. The 
commonalities within soft connective tissue starts at the molecular level with similarities 
in the amino acid sequences (Baer, Cassidy, & Hiltner, 1991). Unlike other classes of 
proteins, collagens contain hydroxyproline. Along with proline and glycine, these three 
amino acids make up more than fifty percent of the total amino acid content in all types 
of collagens. The addition of other amino acids or variations in the amino acid ratios 
differentiates between different collagen types. These amino acids play a significant role 
Figure 2.2: Tendon Hierarchy (Baer et al., 1991) 
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in determining the three dimensional conformation of collagen’s precursor, the 
tropocollagen molecule (Baer et al., 1991).  
 Tropocollagen is made up of three helical polypeptide chains. Longitudinally, five 
tropocollagen molecules aggregate to form microfibrils, which combine to form 
subfibrils (Figure 2.2) (Baer et al., 1991; Wang, 2006). The quarter-staggered 
arrangement of tropocollagen helicies along the length of the subfibril combined with the 
gap between successive macromolecules creates a characteristic 64 nm banding pattern 
that is observed in collagen fibrils (Figure 2.3). Collagen fibrils are well stabilized as a 
result of the covalent intramolecular crosslinks that bind the collagen molecules together 
(Franchi et al., 2007b). A group of collagen fibrils then group together, forming a fascicle 
(or collagen fiber), which is the smallest level of the tendon hierarchy that is able to be 
viewed using light microscopy (Kannus, 2000). Lastly, two or three collagen fibers form 
a tendon (Figure 2.2). In tendons, collagen fibers are arranged in highly ordered parallel 
Figure 2.3: Formation of a collagen fibril from the peptide chains by successive 
polymerizations (Solitchka, 2005; Reproduced under CC BY-SA 3.0 license) 
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bundles along the length of the tendon and serve to enhance the tendon’s response to 
mechanical loading (Franchi et al., 2007a) and resistance to tensile loads (Woo et al., 
1993). 
By using polarized light microscopy, a periodic waveform configuration 
(commonly referred to as “crimp”) is visible at the fascicle level (Diamant, Keller, Baer, 
Litt, & Arridge, 1972; Hansen, Weiss, & Barton, 2002; Franchi et al., 2007b). The angle 
and length of the crimp pattern depend on the type of tendon and the location of the fibers 
in the tendon (Wilmink, Wilson, & Goodship, 1992).  
The predominant type of collagen present in tendons is type I (Kannus, 2000; 
Silver, Freeman, & Seehra, 2003). Type I collagen is a co-polymer of two or more fibril-
forming collagens (Silver et al., 2003; Franchi et al., 2007a). Other forms of fibrillar 
collagens are types II, III, V, and XI (Silver et al., 2003; Canty & Kaddler, 2005). Type I 
collagen is initially synthesized within cells as procollagen chains (Silver & Christiansen, 
1999) and is released from cell membrane invaginations into the ECM, where the chains 
undergo removal of the amino (N--) and carboxyl (C--) terminal non-helical ends, 
becoming tropocollagen (Figure 2.4) (Silver et al., 2003; Franchi et al., 2007a, Canty & 
Figure 2.4: Diagram of procollagen type I molecule (Silver et al., 2003) 
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Kaddler, 2005). During the initial stages of tendon healing, there is an increased presence 
of collagen type III in the tissue in order to provide additional stabilization to the ECM 
(Lin et al., 2004). At the completion of the tendon healing cycle, the homeostatic balance 
of collagen type I to III is restored (Lin et al., 2004).  
 
2.1.2  Tendinous Extracellular Matrix 
Elastin accounts for 1-2% of a tendon’s dry weight whereas collagen makes up 
65-80% of dry mass (Kannus, 2000). Within a collagen fiber, the fibrils are embedded in 
a non-collagenous hydrophilic extracellular matrix, primarily composed of high 
molecular weight hyaluronic acid (HA) with a highly branched aggregate of 
proteoglycans (PGs) (Baer, 1991).  In the extracellular matrix of the tendon there are also 
several glycoproteins present, including Tenascin-C and fibronectin (Wang, 2006). 
Tenascin-C interacts with collagen fibrils and thus contributes to the mechanical stability 
of the ECM (Elefteriou, Exposito, Garrone, & Lethias, 2001). Fibronectin is found on the 
surface of collagens and its synthesis has been reported to increase in order to facilitate 
wound healing (Jozsa et al., 1989, Williams, McCullagh, & Silver, 1984) 
Proteoglycans (PGs) are a heterogeneous family of complex macromolecules 
(Silver & Christiansen, 1999). They are located intracellularly at the cell surface and in 
the extracellular matrix (ECM) and are composed of a core protein with one or more 
glycosaminoglycan (GAG) side chains (Yoon & Halper, 2005; Silver & Christiansen, 
1999). The functions of PGs found in the tendon ECM are not completely understood, 
although research has shown that changes in their rate of turnover have been associated 
with tendinopathies (Riley et al., 1994). In tendons, aggrecans are constitutively 
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expressed and active (Rees et al., 2000). Furthermore, research indicates that aggrecan 
turnover in tendon is much higher than in other connective tissues such as cartilage 
(Waggett, Rees, & Caterson, 2004). The PGs found in tendons are primarily decorin and 
biglycan (Table 2.1) (Kannus, 2000; Magnusson Hansen, & Kjaer, 2003; Franchi et al., 
2007a). Research has revealed that PGs and subsequently GAGs play a critical role in the 
biomechanics of tendon tissue. In 1997, K.G. Danielson and colleagues reported that the 
skin of decorin-deficient mice is unable to withstand sudden tensile strain. Furthermore, it 
has been revealed that the absence of decorin in the tendons of mice was shown to cause 
a decrease in the tendon’s strength and stiffness (Zhang et al., 2006). The properties of 
the most abundant PGs found in tendons can be seen in Table 2.1.  
Glycosaminoglycans (GAGs) are polysaccharide chains, composed of repeating 
disaccharide units (3-Saladin, 2012; Coulson-Thomas & Gesteria, 2014).  Depending on 
the disaccharide unit contained in the GAG, it can be organized into one of five groups: 
chondroitin sulfate, dermatan sulfate, heparin sulfate, keratin sulfate, or hyaluronic acid 
(hyaluronan, HA) (Yoon & Halper, 2005; Coulson-Thomas & Gesteria, 2014). 
Hyaluronan (HA), which is found free in the ECM, is the most abundant GAG in tendon. 
In tendons, the concentration of GAGs is significantly less when compared to cartilage or 
other types of connective tissues (Yoon & Halper, 2005). Beyond their function in the 
tissue biomechanics, GAGs also play a pivotal role in the modulation of cell signals 
(Yoon & Halper, 2005).  
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Table 2.1: Properties and roles of the most abundant PGs found in tendons. (CS = Chondroitin Sulfate, DS = 
Dermatan Sulfate, KS = Keratin Sulfate) (Yoon & Halper, 2005; Iozzo & Murdoch, 1996) 
Name 
Size of core 
protein 
(kDa) 
Type (Number) 
of GAG side 
chains 
Properties and role in tendon 
Decorin 36 CS/DS (1), or CS/DS (1) + KS (1) 
Binds to fibrillar collagen, inhibits collagen 
fibrillogenesis, binds TGFb and EGF 
Biglycan 38 CS/DS (1-2) Binds to fibrillar collagen. 
Fibro-
modulin 42 KS (4) 
Binds to type I collagen, facilitates 
formation of mature large collagen fibrils, 
modulation of tendon strength 
Lumican 38 KS (2-3) 
Binds to type I collagen, inhibits size of 
collagen fibrils, modulation of tendon 
strength 
Aggrecan 220 CS (~100) KS (~60) 
Linked to hyaluronan, provides resiliency, 
low levels in tensional parts of tendon, high 
levels in compressed regions, particularly in 
fibrocartilage 
Versican 265-370 CS/DS (10-30) 
Linked to hyaluronan, low levels in 
tensional parts of tendon, somewhat higher 
levels in compressed regions, increases 
viscoelasticity, maintains cell shape.  
 
2.1.3 Tendon Coverings 
Primary, secondary, and tertiary fiber bundles are each surrounded by a thin 
reticular connective tissue network, called the endotenon, which allows independent 
relative movement of the fascicles within the tendon due to its low friction coefficient 
(Kannus, 2000; Khan, Cook, Kannus, Maffulli, & Bonar, 2002; Rigozzi, 2011).  Tertiary 
fiber bundles are bound together by another type of connective tissue sheath, called the 
epitenon, thus forming a tendon. On its inner surface, the epitenon is continuous with the 
endotenon (Kannus, 2000). While some tendons have true synovial sheaths, a loose 
areolar connective tissue sheath called the paratenon surrounds many tendons. The 
paratenon acts as a sleeve, allowing free movement of the tendon against surrounding 
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tissues, therefore reducing friction (Kannus, 2000). On its outer surface, the epitenon is 
continuous with the paratenon.  
As previously stated, tendons connect muscles to bone. At the tendon-bone 
interface, there is an element called the enthesis. Entheses come in two forms: fibrous 
enthesis or fibrocartilaginous enthesis. The fibrous enthesis attaches to the periosteum 
during childhood or directly to the bone during adulthood (Wang, 2006). The 
fibrocartilaginous enthesis has a transitional zone of hyaline fibrocartilage, which helps to 
distribute the mechanical loads (Wang, 2006). The enthesis is able to bear tensile, 
compressive, and shear forces (Wang, 2006). Furthermore, studies have shown that 
tensile forces at the enthesis may be up to four times greater than at the tendon mid-
substance (Wang, 2006). At the muscle-tendon, or myotendinous, junction, the tendons 
collagen fibrils are inserted into deep recesses formed by myoblasts (Wang, 2006). This 
enables the transmission of tensile forces from contractile proteins in the muscle to 
tendon fibers (Wang, 2006). The myotendinous junction is reported to be the weakest 
point of the muscle-tendon unit (Wang, 2006). Most tendons not only attach to bone, but 
also attach to adjacent dense fibrous connective tissue as a means of dissipating stress 
concentrations at the enthesis. This, in turn, reduces the risk of failure or local wear and 
tear (Benjamin, Kaiser, & Milz, 2008). 
 
2.2  Biomechanics of Tendons 
In response to induced mechanical loading conditions, tendons change their 
structure and biological behavior in response to induced mechanical loading conditions 
(Wang, Guo, & Li, 2012). This ability of connective tissues to alter their structure in 
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response to mechanical loading is called tissue mechanical adaption (or 
mechanoresponse) (Wang, 2006). For example, tenocytes are able to modify their 
behavior based on changing mechanical load (Waggett, Benjamin, & Ralphs, 2006). 
Additionally, research shows that, in vitro, tendon cells can upregulate collagen synthesis 
when subjected to tensional forces; this response is based on gap junctional 
communication (Benjamin et al., 2008). In response to appropriate levels of physical 
training, tenoblasts have been reported to increase production of collagen type I as well 
as increase their cross-sectional area and tensile strength (Tipton, Matthes, Maynard, & 
Carey, 1975; Suominem, Kiiskinen , & Keikinen, 1980; Michna & Hartmann, 1989; 
Landberg, 2001). Researchers have noted that appropriate mechanical loading has 
anabolic effects on tendons, strengthening them and improving their healing quality, 
however, excessive mechanical loading results in injury (Wang et al., 2012).  
A study on the overuse of tendons showed an increase in cellularity and loss of 
normal collagen fiber organization, features characteristic of human tendinopathy 
(Soslowsky et al., 2000). The study also showed a marked decline in tendon mechanical 
properties, including elastic modulus and maximum stress at failure. Excessive 
mechanical loading conditions have been shown to cause abnormal differentiation of 
tendon stem cells, which could contribute to the development of tendinopathy (Zhang & 
Wang, 2010a; Zhang & Wang, 2010b; Wang et al., 2012). Additionally, researchers have 
reported that, in mice subjected to intense treadmill running, an increase in the amount of 
myofibroblasts was observed (Szczodry et al., 2009). Myofibroblasts are a type of 
activated fibroblast, involved in the repair and remodeling of injured tissues (Hinz et al., 
2001, Tomasek et al., 2002). Their presence following exercise is indicative of active 
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repair and remodeling of the tendon tissue which might have been microinjured as a 
result of the imposed mechanical loading on the tendon (Wang et al., 2012). 
 
2.2.1 Viscoelasticity and Stress-Strain Curve 
The typical stress strain 
curve of a tendon begins with an 
initial toe region, in which the 
tendon is strained up to 2% 
(Figure 2.5) (Wang, 2006). This 
region represents the stretching 
out of the “crimp”. As previously 
mentioned, the angle and length 
of this crimp pattern vary between 
and within tendons; the differences in the crimp pattern affect the tendon’s mechanical 
properties (e.g., tendons with small crimp angle fail before those with larger crimp angle) 
(Wilmink et al, 1992).  
The next section of the stress-strain curve is referred to as the linear region 
(Figure 2.5). In this region, the tendon is stretched less than 4% and the collagen fibers 
lose the crimp pattern (Wang, 2006). The slope of this region is equal to the Young’s 
modulus of the tendon. If the tendon is stretched beyond 4%, microscopic tearing of the 
collagen fibers occurs (Wang, 2006). Additionally, strain beyond 8-10% will induce 
macroscopic failure and eventually tendon rupture (Figure 2.5) (Butler, Grood, Noyes, & 
Zernicke, 1987). 
Figure 2.5: Tendon stress-strain curve (Wang, 2006) 
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Similar to other soft tissues like ligaments and skin, tendons are viscoelastic and 
are thus sensitive to different strain rates (Wang, 2006). It is inferred that this viscoelastic 
behavior is due to collagen, water, and interactions collagenous proteins and non-
collagenous proteins (e.g., PGs) (Wang, 2006). A tissue’s viscoelasticity is defined by 
stress-relaxation, creep, and hysteresis (Butler et al., 1987). Due to the viscoelasticity 
attributed to tendons, they are more deformable at low strain rates and are therefore able 
to absorb more energy but are less effective at transferring loads (Wang, 2006; Wang et 
al., 2012). However, at high strain rates, tendons become less deformable and have a high 
degree of stiffness, which allows them to be more effective at moving larger muscular 
loads to bones (Jozsa & Kannus, 1997; Wang et al., 2012). 
 
2.2.2 Mathematical Models 
Mathematical models have been developed as a means to complement 
experimental studies on the mechanics of tendon behavior. They also serve to provide 
researchers with the potential to predict the mechanical behavior of the tissue beyond the 
experimental limits. Earlier models focused on describing the nonlinear aspects of a 
tendon’s stress-strain response and ignored the time-dependent components. However, in 
the last 50 years, models have been developed with incorporate the time- and history-
dependency of the relationship and thus the viscoelasticity (Woo et al., 1993).  
 
2.3  Tendon Injuries and Repair 
 In response to tendon injury, the body initiates a series of events consisting of 
healing and scar formation (Lin et al, 2004). T.W. Lin and colleagues (2004) divided 
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these events into three separate phases: (1) hemostasis/inflammation, (2) proliferation/ 
fibroplasia, and (3) remodeling/maturation (Figure 2.6). The initial phase of tendon 
healing, hemostasis/inflammation, occurs immediately following injury. In order to 
stabilize the newly forming extracellular matrix, there is a significant increase in the 
tendon’s DNA, fibronectin, GAGs, water, and collagen type III content (Lin et al., 2004; 
Woo et al., 2000a; Woo et al., 2000b; Joza & Kannus, 1997; Gomez, 1995; Montgomery, 
1989; Grinnell, 1984). During the second phase of tendon healing, the main cell type 
present is fibroblasts, followed by a smaller number of macrophages and mast cells (Lin 
et al., 2004). An increase in the endoplasmic reticulum of fibroblasts, a clear sign of 
active matrix synthesis, has been shown to occur in this phase (Lin et al., 2004, Jozsa & 
Kannus, 1997).  Collagen type III and DNA concentrations are also known to reach their 
peak levels during this phase (Lin et al., 2004). In the third and final stage of tendon 
healing, the tendon’s ratio of type III to type I collagen returns to normal ranges. 
Furthermore, the concentrations of GAGs, water, and DNA also return to normal levels.  
Although, over time, the tensile strength of the injured tendon will return to a near-
normal range, it will never achieve the optimal tensile strength of uninjured normal 
tendons (Figure 2.6) (Gomez, 1995; Lin et al., 2004).  
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CHAPTER THREE 
LITERATURE REVIEW: RADIATION 
 
3.1  Introduction to Radiation 
3.1.1  Types of Radiation 
Radiation is defined as the emission and propagation of energy from a source 
through space or matter in the form of waves or energized particles (Donya, Radford, 
ElGuindy, Firmin, & Yacoub, 2014). There are two main types of radiation, ionizing and 
nonionizing (Figure 3.1).  When people think of radiation, they generally think of 
ionizing radiation, such as x-rays or gamma (γ) rays. However, there are many common 
types of nonionizing radiation, including thermal radiation, radio waves, microwaves, 
infrared light, visible light, and most ultraviolet (UV) light. When compared to ionizing 
Figure 3.1: Electromagnetic Radiation Spectrum with Radiation Types (U.C. Davis Chem. Wiki, 
Figure reproduced under the CC BY-NC-SA 3.0 license) 
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radiation, nonionizing radiation has longer wavelengths, lower frequencies, and 
insufficient energy per quantum to ionize matter (Environmental Protection Agency, 
2015). Although nonionizing radiation is generally considered safer than ionizing 
radiation, some forms have been shown to cause damage similar to that of ionizing 
radiation. For example, while small amounts of UV radiation are essential to the 
production of vitamin D, prolonged human exposure to solar UV radiation may result in 
photoaging, immunosuppression, and ultimately photocarcinogenesis (Matsumura & 
Ananthaswamy, 2004). At the molecular level, UV radiation causes damage to DNA. 
Furthermore, the UV radiation present in sunlight has been classified as an environmental 
human carcinogen (Matsumura & Ananthaswamy, 2004).  
 Ionization is defined as the transfer of enough energy to a medium that is 
sufficient to overcome the binding energy of an electron, causing the electron to be 
ejected from the atom, thus forming an ion (Mettler & Upton, 1995). Ionizing radiation 
deposits a relatively large amount of energy into a small area when compared to other 
types of radiation (Mettler & Upton, 1995). There are four main types of ionizing 
radiation: alpha particles, beta particles, x-rays, and gamma (γ) rays. Alpha particles are 
emitted from the 
decay of only the 
heaviest radioactive 
nuclei, such as 
uranium or radium 
(Donya et al., 
2014). While very Figure 3.2 Graphic showing penetrating power of alpha, beta, & gamma 
radiation (Donya et al., 2014; Christiansen 1988) 
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energetic and highly ionizing, the weight and size of alpha particles cause them to lose 
energy over a small distance, allowing them to easily be stopped by paper or skin (Donya 
et al., 2014) (Figure 3.2). Only when inhaled or ingested are alpha particles dangerous 
due to highly focused ionization, which causes severe damage at both cellular and genetic 
levels (Rutherford, 1911; Krane, 1988). Compared to alpha particles, beta particles are 
much smaller and only carry about half of the electrical charge of alpha particles (Mettler 
& Upton, 1995). Beta particles have a much greater penetration range, and are capable of 
traveling several feet through the air and a few millimeters into tissue, but are easily 
stopped by clothing or a thin sheet of aluminum (Donya et al., 2014). However, because 
their ionization is spaced over a larger area, beta particles cause less damage than alpha 
particles. Unlike alpha and beta particles, X-rays and γ-rays do not have mass or charge. 
γ-rays have a significantly higher penetration range, requiring several inches of lead or 
several feet of concrete to stop them, while X-rays are generally less penetrating due to 
their lower energy (Donya et al., 2014). X-rays are known to occur naturally, but, as 
discovered by Roentgen, can also be produced by machines and are used every day 
throughout the world in the form of medical imaging machines (x-ray, CT scan, MRI, 
etc.) and airport security scanners, to name a few. Because γ-rays can easily pass through 
the whole human body, they have the potential to cause severe damage to tissue and 
DNA. This unique capability of γ-rays has been harnessed for use in medical science, in 
the form of radiation therapy for cancer (Donya et al., 2014; Hamada & Fujmichi, 2014).  
The main types of ionizing radiation can be further categorized into two 
categories: electromagnetic radiation or particulate radiation. X-rays and γ-rays fall under 
the category of electromagnetic radiation while electrons, protons, neutrons, alpha 
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particles, and beta particles are types of particulate radiation (Azzam, Jay-Gerin, & Pain, 
2012). Alpha and beta particle radiation are further categorized as directly ionizing, 
meaning that the charged particles (α and β particles) strike the tissue or medium and 
interact directly with the target molecules. X-rays and γ-rays are categorized as indirectly 
ionizing, meaning that they give up their energy in various interactions. The energy is 
then used to produce a fast moving charged particle, like an electron, which then 
secondarily interacts with the target molecule (Mettler & Upton, 1995).  
X-rays and γ-rays have many of the same properties. As previously stated, they 
are massless and carry no charge. They also both originate from energy released by 
unstable atoms; γ-rays originate from the nucleus and x-rays originate from the electrons. 
Unlike alpha and beta particle radiation, x-rays and γ-rays have a long penetration range 
and are made up of photons, which are massless particles that represent quanta or packets 
of energy transmitted in the form of wave motion (Martin & Harbison, 1996). The 
amount of energy contained in each quantum is inversely proportional to the wavelength 
of the radiation (Martin & Harbison, 1996). In other words, the shorter the wavelength, 
the higher the energy. The wavelengths of electromagnetic radiation vary over a wide 
range, as seen in Table 3.1.  
 
 27 
Table 3.1: Wavelengths of electromagnetic radiation (Martin & Harbison, 1996) 
Type	  of	  Radiation	   Wavelength,	  λ	  (metres)	  Radio	  waves,	  long	  wave	   1500	  Radio	  waves,	  VHF	   3	  Visible	  light	   10-­‐6	  to	  10-­‐7	  X-­‐rays,	  50	  keV	  energy	   2.5	  x	  10-­‐11	  γ-­‐rays,	  1	  MeV	  energy	   1.2	  x	  10-­‐12	  
 
3.1.2  Radiation Units of Measurement 
There are four units for measuring radiation: radioactivity, exposure, absorbed 
dose, and effective dose (Donya et al., 2014). Radioactivity is the measurement of the 
spontaneous nuclear transformation or radioactive decay of radionuclides (Turner, 2007). 
In order to measure the radioactivity of a substance, the number of nuclei that decay per 
unit time is measured (Close & Ludwig, 2000). The standard international (SI) unit for 
radioactivity is the becquerel (Bq). One bequerel is equal to one disintegration per second 
(Table 3.2) Close & Ludwig, 2000; Bertulani, 2007). The radioactivity of a unit weight of 
a substance is the specific activity, measured in becquerel per gram (Bq/g) (Close & 
Ludwig, 2000). The specific activity allows the comparison of different radioactivity 
levels between substances (Close & Ludwig, 2000). Exposure is a measure of the amount 
of ionizations produced by electromagnetic radiation in the air (Turner, 2007). The 
traditional unit of measurement for exposure is the roentgen (R), which is equal to 
2.58x10-4 coulomb per kilogram (of air). Coulomb per kilogram ( !"#	  ) is the SI unit of 
measurement for exposure (Table 3.2).  
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Table 3.2: Measurements of radiation and their respective units. (Close & Ludwig, 2000; Turner, 2007; 
Bertulani, 2007) 
Measurement Traditional Unit SI Unit 
Radioactivity 
Curie (Ci);                            1	Ci = 3.7×10+,dps  Becquerel (Bq); 1	Bq = 1	dps = 0.27×10-/0Ci   
Exposure 
Roentgen (R);                          1	R = 2.58×10-, -./	01	234   Coulomb/kilogram (C/kg) of air 
Absorbed 
Dose 
Radiation absorbed dose 
(rad); 1	rad = 100 ()**   Gray (Gy);                       100	rad = 1	Gy = 1 *+,  
Equivalent 
Dose 
Roentgen equivalent man 
(rem); 1 rad = 1 rem 
Sievert (Sv);                            
1 Sv = 100 rem 
Linear Energy 
Transfer 
(LET) 
keVµm = 10MeVcm   Newton (N); 1	MeV	 = 	1.602×10,-.Nm  
 
To evaluate the hazard resulting from biological exposure to radiation, the 
absorbed dose must be computed. Absorbed dose is a point function that measures the 
energy imparted to a defined mass of tissue (Eichholz & Poston, 1967; Bertulani, 2007; 
Close & Ludwig, 2000; Turner, 2007). The traditional unit for measuring absorbed dose 
is the rad (radiation absorbed dose): 1 rad = 10-2 J/kg of material (Table 3.2). However, 
the SI unit for absorbed dose is the Gray (Gy): 1 Gy = 1 J/kg = 100 rad (Table 3.2). 
Another measurement of dose, equivalent dose (also referred to as radioactive 
dose equivalent), was introduced to allow for different levels of biological effectiveness 
of different kinds of radiation (Turner, 2007). Equivalent dose is a point function and 
measures the absorbed dose and the biological effects of the specific type of radiation 
observed (Turner, 2007). The formula to calculate the equivalent dose is H = D	×	W'  ,
where H is the dose equivalent, D is the absorbed dose, and WR represents the weighting 
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factor, as seen in Table 3.3. The traditional unit of measurement for equivalent dose is the 
roentgen equivalent man (rem), whereas the SI unit is the sievert (Sv) (Table 3.2). The 
weighting factor represents the relative biological effectiveness (RBE) of the radiation 
and serves to provide an absorbed dose that is representative of the various types of 
radiation and the energies associated with them. The relationship between these 
measurements and their respective SI units can be seen in Figure 3.3.  
In the early 1950s, the concept of linear energy transfer (LET) was introduced in 
order to characterize the rate of energy transfer per unit distance along a charged-particle 
track (Turner, 2007). LET is therefore synonymous with stopping power. LET is usually 
expressed in units of keV/µm of water, which converts to 10 MeV/cm (Table 3.2) 
(Turner, 2007). According to the National Institute of Standards and Technology (NIST), 
there currently is not an SI unit for LET (NIST, 2015).  
 
Table 3.3: Weighting factors for different types of radiation according to the International Council 
on Radiological Protection Report 103 (International Commission on Radiological Protection, 2007) 
Radiation Type Energy  WR  
α particles    20 
β particles    1 
X-rays, gamma rays    1 
Neutrons  
< 1 MeV  2.5 + 18.2'-[*+(-)]01  
 
1 - 50 MeV  5.0	 + 	17.0(-[+, -.]0 -     
> 50 MeV  2.5 + 3.25&-[)*(,.,-.)]1 2  
 
Protons    2 
Heavy nuclei    20 
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Figure 3.3: Graphic displaying the relationship between different measurements of radiation dose. 
(Doug Sim, figure reproduced under CC BY--SA 3.0 license) 
 
3.2  Biological Effects of Radiation 
 The biological effects of radiation depend on the amount of energy transferred to 
the tissue (Mettler & Upton, 1995). At low doses, radiation is known to initiate an only 
partially understood chain of events, leading to cancer or genetic damage and, 
additionally, cell death (U.N. Environment Programme, 1991). Although the effects of 
low-dose radiation are not clearly understood, they are of increasing societal importance 
in varied aspects such as routine cancer screenings, frequent air travel, occupational 
exposure (especially in the field of nuclear power), manned space travel, or the potential 
for radiological terrorism (Table 3.3) (Brenner et al., 2003). 
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Table 3.4: Approximate mean doses relevant to societal low-dose radiation exposures and to low-dose 
radiation risk estimation (Brenner et al., 2003) 
 Approximate mean 
individual dose, 
mSv* 
Some societally relevant exposures  
Round-trip flight, New York to London 0.1 
Single screening mammogram (breast dose) 3 
Background dose due to natural radiation exposure 3/yr 
Dose (over a 70-year period) to 0.5 million individuals in 
rural Ukraine in the vicinity of the Chernobyl accident 
14 
Dose range over 20-block radius from hypothetical 
nuclear terrorism incident [FASEB scenario 1: medical 
gauge containing cesium (6)] 
3–30 
Pediatric CT scan (stomach dose from abdominal scan) 25 
Radiation worker exposure limit (1) 20/yr 
Exposure on international space station 170/yr 
Some low-dose epidemiological studies  
A-bomb survivors [mean dose in LSS cohort (2)] 200 
Medical x-rays [breast dose in scoliosis study (4)] 100 
Nuclear workers [mean dose from major studies (5)] 20 
Individuals diagnostically exposed in utero (3)  10 
* NOTE: Sivert measures equivalent dose and Grey measures absorbed dose. 
1 mSv = 1 mGy (see Figure 3.3). 
 
3.2.1 Oxidative Changes  
Research has shown that oxidative changes continue to occur days or even months 
after the initial radiation exposure. This is thought to be a result of continuous generation 
of reactive oxygen (ROS) and reactive nitrogen (RNS) species (Petkau, 1987; Azzam et 
al., 2012). At normal levels, ROS/RNS take part in signal transduction functions that are 
essential to healthy survival (Azzam et al., 2012; Finkel, 2000). However, at aberrant 
levels, they function as toxic agents and have been associated with abnormal cell 
proliferation (Azzam et al., 2012; Oberley & Oberley, 1988). Furthermore, these 
processes are not only limited to the irradiated cells but are also seen in their progeny as 
well as in bystander cells by means of intercellular communication mechanisms (Azzam, 
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Toledo, & Little, 2003; Mothersill & Seymour, 2004; Kryston, Georgiev, Pissis, & 
Georgakilas, 2011; Azzam et al., 2012). This knowledge is of utmost importance because 
the perseverance of these stressful events in progeny cells has numerous implications for 
long-term health risks, including but not limited to the emergence of a second malignancy 
following radiotherapy treatments (Azzam et al., 2012; Hall, 2004; Cucinotta & 
Chappell, 2010; National Research Council of the National Academies, 2005). 
Furthermore, there is increasing evidence supporting the role of chronic oxidative stress 
in the progression of degenerative diseases and radiation-induced late tissue injury 
(Azzam et al., 2012; Spitz, Azzam, Li, & Gius, 2004; Schonfeld et al., 2010; Zhao & 
Robbins, 2009).  
 Cells respond to the increased generation of reactive species and up-regulate 
signaling cascades to in response to the increased stress conditions, for example research 
has shown that following exposure to low LET radiations (X- & gamma- rays), adaptive 
responses encompassing DNA repair and antioxidation reactions may be triggered (de 
Toledo et al., 2006; Feinendegen, Pollycove, & Neumann, 2007; Wolff, 1998). 
Additionally, metabolic protections are mobilized during and soon after the insult at 
molecular, cellular, tissue, and organism levels (Azzam et al., 2012; Feinendegen, 
Brooks, & Morgan, 2011). DNA repair mechanisms are upregulated, antioxidants 
scavenge excess ROS, proteases remove oxidized proteins, some cellular immune 
responses are activated, and cells/tissues may downregulate oxidative metabolism in 
order to lower the concentrations of reactive chemical species (Azzam et al.,, 2012; 
Buonanno, de Toledo, Pain, & Azzam, 2011; Pandey, de Toledo, Pain, & Azzam, 2006; 
Ina & Sakai, 2005). The track structure (LET) of the impacting radiation is critical to 
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determine the nature of long-term effects on oxidative metabolism (Buonanno et al., 
2011; Buonanno, de Toledo, & Azzam, 2011). Depending on the radiation dose, dose-
rate, and radiation quality, the protective mechanisms elicited by the cells may not be 
adequate to cope with the induced stresses. It has been reported that approximately 60 
ROS per nanogram of tissue are generated within less than a microsecond following a hit 
from 137Cs gamma rays and that a nuclear concentration of ROS of that magnitude can 
cause extensive oxidative injury and modify normal biochemical reactions (Nikjoo, 
Goodhead, Charlton, & Paretzke, 1991; Sutherland, Bennett, Sidorkina, & Laval, 2000).  
Furthermore, in irradiated cells, disturbances in the oxidative metabolism and 
chronic inflammatory responses may cause an increase in the levels of ROS and RNS, 
leading to long-term effects on genomic stability (Azzam et al., 2012).  
 
3.2.2  Radiation-Induced Genomic Instability 
Genomic instability is characterized by a high frequency of mutations in the 
mammalian genome (Morgan, Day, Kaplan, McGhee, & Limoli, 1996). Ionizing 
radiation can interfere with various metabolic pathways, specifically those which govern 
DNA duplication or serve to maintain the integrity of the information encoded by DNA. 
This interference causes genomic instability, which leads to an increase in the frequency 
of mutations, gene amplification, and karyotypic alterations (Morgan et al., 1996).  
Furthermore, cellular exposure to ionizing radiation results in a variety of directly- and 
indirectly-induced DNA lesions, including DNA base alterations, DNA-DNA and DNA-
protein crosslinks, and single- and double-strand breaks (Ward, 1988; Morgan et al., 
1996).  
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Irradiation induces many biological responses in a cell, such as the initiation of 
signal transduction pathways, activation of gene transcription, repair of damaged DNA, 
and cell cycle-specific growth arrest (Morgan et al., 1996; Weichselbaum, Hallahan, 
Sukhatme, Dritschilo, Sherman, & Kufe, 1991; Ward, 1984). Early events are likely to be 
factors in the irradiated cell’s later fate; in other words, whether the cell will necrose, 
senesce, apoptose, or ultimately survive and proliferate (Morgan et al., 1996). If the cell 
survives, the initial biological response to the radiation may have bearing on whether the 
cell carries on as normal, acquires a limited lifespan, or subsequently proliferates and, by 
means of genomic instability, begins to take on the characteristics of a normal cell 
transitioning into a cancerous cell (Morgan et al., 1996). 
In addition to immediate biological responses, several delayed effects in the 
progeny of irradiatied cells have been identified. These delayed effects include giant cell 
formation, cell fusion, delayed mutation, and delayed chromosomal instability (Morgan 
et al., 1996; Seymour, Mothersill, & Alper, 1986; Chang & Little, 1992; Mothersill & 
Seymour, 1987).  
3.2.2  Radiation-Induced Cell Death 
Ionizing radiation causes single & double strand breaks in DNA, an event that is 
generally lethal (Grasl-Kraupp, Ruttkay-Nedecky, Koudelka, Bukowska, Bursch, & 
Schulte-Hermann, 1995; Cohen-Jonathan, Bernhard, & McKenna, 1999). Irradiation also 
damages the cell membrane, thus inducing pathways that may cause or contribute to cell 
death (Cohen-Jonathan et al., 1999). There are two ways by which radiation can lead to 
cell death: via apoptosis or necrosis. Apoptosis is defined as programmed cell death and 
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is considered to be an active process of cellular suicide (Cohen-Jonathan et al., 1999). 
Apoptotic cells are characterized by loss of membrane integrity following DNA 
degradation (Wyllie, Kerr, & Currie, 1980; Dewey, Ling, & Meyn, 1995). On the other 
hand, necrosis is considered to be a passive process resulting from cells containing 
unrepaired DNA breaks and lethal chromosomal aberrations from passing through 
mitosis (Cohen-Jonathan et al., 1999).  In necrotic cells, the integrity of the membrane is 
lost prior to DNA degradation (Wyllie et al., 1980; Dewey et al., 1995). DNA 
degradation in necrotic cells is generally random without proof of specificity in size 
ranges, while in apoptotic cells, DNA degradation seems to be restricted to certain size 
ranges (Olive, Frazer, & Banath, 1993, Dewey et al., 1995). It is hypothesized that 
apoptosis is programmed by specific signals in the cell that causes an endonuclease to 
cleave DNA at internucleosomal sites (Dewey et al., 1995). Morphologically, apoptosis is 
initiated by condensation of nuclear chromatin, then blebbing of the nuclear and 
cytoplasmic membranes, and lastly by formation of membrane-bound apoptotic bodies 
(Wyllie, 1992; Grasl-Kraupp et al., 1995; Cohen-Jonathan et al., 1999). The onset of 
apoptosis varies between cell types. It can occur immediately after irradiation (interphase 
death, fast apoptosis), after G2 arrest, or after one or more cell divisions (late apoptosis) 
(Radford, Murphy, Radley, & Ellis, 1994; Dewey et al., 1995; Yanagihara et al., 1995; 
Cohen-Jonathan et al., 1999). 
3.3  Radiation Therapy for Cancer 
Radiation therapy is used in the field of oncology to manage or treat various 
forms of cancer. It uses high-energy radiation to shrink tumors and kill cancer cells 
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(Lawrence, Ten Haken, & Giaccia, 2008). The radiation kills the cancer cells by 
damaging their DNA either directly or indirectly via the creation of free radicals 
(National Cancer Institute, 2010). Once the cell’s DNA is damaged beyond repair, the 
cells stop dividing and die. They are then broken down and removed by the body’s 
natural processes. While radiation therapy targets cancer cells, normal cells can also be 
damaged or killed, resulting in negative side effects.  
Radiation therapy can be given both with curative or palliative intent. Curative 
intent means that the treatment is administered with the hope that it will cure a cancer by 
eliminating a tumor, preventing recurrence of the cancer, or both (Lawrence et al., 2008). 
On the other hand, palliative intent means that the therapy is not intended to cure the 
cancer but instead to relieve symptoms and/or reduce a patient’s suffering (National 
Cancer Institute, 2010).  
There are three ways in which radiation therapy can be given to patients: external-
beam radiation therapy, internal radiation therapy (or brachytherapy), or systemic 
radiation therapy (National Cancer Institute, 2010). External-beam radiation therapy 
comes from a radiation source outside of the body while brachytherapy comes from a 
radioactive material that is placed inside the body near the cancer cells. Systemic 
radiation therapy involves a radioactive substance, given orally or intravenously, which 
travels to the tissues by way of the bloodstream. The choice of radiation therapy 
prescribed by the oncologist depends on various factors, including the type, size, or 
location of the cancer.  
External beam radiation therapy is usually delivered in the form of photon beams 
(x-rays or γ-rays) (Lawrence et al., 2008). This form of treatment is usually administered 
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in fractionated doses; in other words, given in daily treatment sessions over the course of 
several weeks. The main reason for daily treatment fractions is two-fold: first, to 
minimize the damage to normal tissues, and secondly to increase the likelihood that the 
cancer cells are exposed to radiation at critical points in their cell cycle when they are 
most susceptible to DNA damage (Lawrence et al., 2008, Connell & Hellman, 2009).  
In internal radiation therapy, or brachytherapy, radioactive isotopes are sealed in 
tiny pellets and placed in patients via a carrier such as needles or catheters. As these 
isotopes naturally decay, they give off radiation that damages neighboring cancer cells. 
Examples of where these pellets could be placed include interstitial brachytherapy, where 
the source is placed within the tumor tissue, or intracavitary brachytherapy, where the 
source is placed within a surgical or body cavity. This form of treatment may be able to 
deliver higher doses of radiation to some forms of cancer than external beam therapy 
while causing less damage to normal tissues (Patel & Arthur, 2006; Lawrence et al., 
2008).  
Brachytherapy can be used alone or in addition to external-beam radiation therapy 
(Patel et al., 2006). During systemic radiation therapy, the patient either swallows or is 
injected with a radioactive substance, like radioactive iodine or a radioactive substance 
bound to a monoclonal antibody (National Cancer Institute, 2010). Radioactive iodine 
(131I) is commonly used to treat some types of thyroid cancer because thyroid cells 
naturally take up 131I. For some other forms of cancer, the monoclonal antibody helps 
take the radioactive substance to the correct location.  
Radiation therapy is known to cause both acute and chronic side effects. While 
acute side effects occur during treatment, the chronic side effects occur months or years 
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after the end of treatment (Lawrence et al., 2008). Factors that contribute to the side 
effects include the area of the body being treated, the dose given per day, the total dose 
given, the patient’s medical condition, or any other treatments being given at the same 
time (National Cancer Institute, 2010).  
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CHAPTER 4 
MATERIALS AND METHODS 
 
4.1  Tissue Harvest and Culture 
 
Digital flexor tendons were excised from the forefeet of hogs (Vaughns’ Meat 
Processing Co., Greer, SC). In a sterile dissection hood, the tendons were carefully 
removed, cut to a length of approximately 20 ± 0.20 mm (Figure 4.1), and placed in an 
anti-microbial wash containing 
protease inhibitors, 2 mM phenyl 
sulfonyl fluoride, 5 mM EDTA, 5 
mM N-ethylmaleimide, and 5 mM 
benzamidine hydrochloride for 20 
minutes (Appendix A). For each foot, 
four samples were taken, two for the 
control group and two for the 
irradiated group. After 20 minutes, the tendon sections were rinsed with media (Appendix 
B), divided into groups, and placed in sample cups containing 20 mL of the same media. 
The tendon sections remained in the media for a minimum of 24 hours prior to 
irradiation. During this time, the samples were cultured at 37°C and 5% CO2 in low-
glucose Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco) supplemented with 
10% fetal bovine serum (FBS) (Atlanta Biologicals, Lawrenceville, GA), and 1% 
nonessential amino acids. The tendon media was then changed 4 hours prior to irradiation 
and again every 48 hours after irradiation. The media of the non-irradiated samples was 
changed at the same times as that of the irradiated samples.  
Figure 4.2: Porcine tendon in dissection hood, measuring 
before cutting 
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4.2  Gamma Irradiation 
After the tendon samples were equilibrated for at least 24 hours in tissue culture 
conditions, the media was replaced with fresh media approximately four hours prior to 
irradiation (30 minutes to 1 hour before leaving Clemson and taking the samples to Wake 
Forest Baptist Health Center in Winston-Salem, North Carolina). All harvested tendon 
samples were transported in a mobile incubation unit (United Laboratory Plastics, 
Fenton, MO) for irradiation via gamma rays from a Cesium-source radiation unit at Wake 
Forest Baptist Health. The samples to be irradiated received a dose of 5 Gray (Gy) 
Cesium gamma rays. Even though they were not irradiated, the control samples were 
transported to Wake Forest Baptist Health alongside the irradiated samples in order to 
control for any issues that might occur during the travel between institutions.  
4.3  Histology  
On days 3 and 5 post-irradiation, 
samples were taken from both the control and 
irradiated groups and placed in 10% Neutral 
Buffered Formalin (NBF) for 24 – 48 hours. 
The sections were then cut to a thickness of 
Figure 4.3: Tendon tissue samples in cassettes before going into tissue processor 
Figure 4.2: Tissue sections cut to approx. 2mm 
thickness in petri dish in serile conditions 
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approximately 2 mm in preparation for tissue processing (Figure 4.2). The samples were 
placed in tissue processing cassettes based on category and placed in a tissue processor 
for 8 hours. Following processing, the samples were placed in a warming tray and 
embedded in paraffin (TissueTek®, Sakura, Torrance, CA).  
 
4.3.1  H&E, Masson’s Trichrome, Safranin-O, and Alizarin Red-S 
Using a microtome (Lecia Biosystems, Buffalo Grove, IL), the samples were 
mounted on charged slides and placed in an oven (VWR Scientific Inc., Radnor, PA) at 
60°C for a minimum of 48 hours prior to histological staining. The tissue sections 
mounted on charged slides were stained with Hemotoxalin & Eosin (Appendix D), 
Masson’s Trichrome (Appendix E), Safranin-O (Appendix F), and Alizarin Red S 
(Appendix G).  Detailed protocols are in the appendices.  
Hemotoxylin is a basic, positively charged stain which binds to basophilic 
substances like DNA and RNA and stain them purple. Eosin is an acidic, negatively 
charged stain that binds to acidophilic substances, namely positively charged amino acid 
side chains, staining them pink. Together, they make up the H&E stain. H&E stains 
collagen pale pink, muscle deep pink, acidophilic cytoplasm red, basophilic cytoplasm 
purple, nuclei blue, and erythrocytes bright red. This stain allows for observation of the 
samples to look for morphological signs of apoptosis prior to application of a chemical 
assay to highlight DNA fragmentation. A clear morphological change associated with 
apoptosis is a specific pattern of chromatin condensation, made visible by the 
hematoxylin, which is of crucial importance for diagnostic purposes (i.e. oncological 
diagnosis) (Fischer, Jacobson, Rose, & Zeller, 2008).  
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Masson’s Trichrome is a stain which uses three different dyes to selectively stain 
muscle, collagen fibers, fibrin, and erythrocytes. Clinically, it is used to differentiate 
between collagen and smooth muscle in tumors and to show an increase in collagen 
presence in tissue, usually as a result of certain diseases. A red, acidic dye, Biebrich 
scarlet, binds to the acidophilic tissue components. The sample is then treated with 
phospho acids, which pull the red dye out of the collagen while the less permeable tissue 
components retain the Biebrich scarlet (University of Utah, 2016). The application of 
aniline blue then colors the collagenous tissue components blue (University of Utah, 
2016). After completion of the Masson’s Trichrome staining protocol, the muscle/keratin 
is stained red, cytoplasm appears pink, cell nuclei are dark brown to black, and collagen 
is a vivid blue (Appendix E).  
The Safranin-O staining method is generally used for the detection of cartilage, 
mucin, and mast cell granules in formalin-fixed, paraffin-embedded tissue sections 
(Appendix F). Safranin-O is a cationic stain that stains acidic proteoglycans (PGs) 
present in tissue sections (Takara Bio Inc.). Safranin-O is used to detect aggrecan and 
collagen (Takara Bio Inc.) in orthopedic tissues. As previously mentioned, there is a 
significant presence of aggrecan in tendon tissue. Therefore, if radiation results in an 
increase or decrease in levels of PGs in the tendon matrix, this can be identified by 
examining the samples for an increased presence of Safranin-O in the irradiated samples. 
The counterstain, fast green, is a sulfate-group-containing substrate which strongly stains 
the non-collagen sites by binding strongly to the amino group of proteins. When this stain 
is applied to tissue sections, the nuclei stain black; the cytoplasm stains a grey-green 
color; and  mucin, and mast cell granules stain orange to red.  
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Alizarin Red S is a staining procedure that is used to detect microcrystalline 
phosphate salts. Clinically, it is used to detect calcium deposits in liver tissue. In tissue 
sections, calcium forms Alizarin Red S—Ca complexes in a chelation process. The end 
product is birefringent. The Alizarin Red S allows identification of calcium deposits by 
dying them an orange to red color.  
 
4.4 In Situ Apoptosis Detection 
Apoptosis detection was carried out using the TACS ® 2 TdT-DAB In Situ 
Apoptosis Detection Kit (Trevigen Inc., Gaithersburg, MD) (Appendix H). This kit was 
designed for the detection of cellular apoptosis in tissue sections. The data obtained from 
this assay is to be used in conjunction with morphological data obtained via standard 
microscopy. 
Terminal deoxynucleotidyl Transferase (TdT) binds to the exposed 3’-OH ends of 
DNA fragments generated in response to apoptotic signals and catalyzes the addition of 
biotin-labeled deoxynucleotides (Abcam). A streptavidin-horseradish peroxidase (HRP) 
conjugate is used to detect biotinylated nucleotides and diaminobenzidine (DAB) 
subsequently reacts with the HRP-labeled cellular components and creates an insoluble 
brown substrate at the site of DNA fragmentation (Abcam). The Methyl Green 
counterstain allows the visualization of cells in the tissue sample. Cells that are pyknotic, 
mitotic, or apoptotic will exhibit an increased uptake of Methyl Green (Trevigen Inc., 
2015).  
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4.5  Quantification of Glycosaminoglycan Concentration 
The rate GAG degradation and synthesis were analyzed by measuring the 
concentration of sulfated GAGs (sGAG) in the tendon tissue digests and in the media of 
irradiated and non-irradiated samples using a dimethylmethelene blue (DMMB) assay.  
Culture media (15 mL) was taken from all samples daily following irradiation for 
5 days and stored in conical tubes at -20°C. Tendon tissue samples were taken 3 and 5 
days after irradiation and were stored with 15mL of fresh media at -20°C until ready to 
use, at which time they were brought to room temperature in the water bath (37°C). A 
collagenase tissue digestion 
procedure was then performed on 
the tendon tissue samples. They 
were digested separately by 
category using a modification of a 
previously described method 
(Mazzocca et al., 2012) using 
bovine serum albumin (fraction V) 
in low-glucose DMEM and Collagenase Type I (Appendix I).  
Culture media and tissue digests were then tested for sGAG content using the 
dimethylmethelene blue (DMMB) assay (Appendix J). Using a 96-well plate, 200µL of 
dimethylmethylene blue was added to 20µL of each sample. The standard curve was 
created using increasing concentrations of chondroitin sulfate (Sigma-Aldrich) in order to 
determine a linear regression equation (Figure 4.4).  Immediately, absorbance was read 
using a Synergy 4 microplate reader at 525nm (BioTek, Winooski, VT). The plate of the 
Figure 4.4: Plate for standard curve with increasing 
concentrations of chondroitin sulfate 
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microplate reader was programmed to shake slowly for five seconds prior to reading the 
absorbance. The sGAG content for each sample was determined by substituting the 
absorbance measurements into the linear regression equation given by the standard curve.  
 
4.6 Statistics 
For the Masson’s Trichrome Stain, the RGB measurements were taken from a 
large pool of images taken of the slides (n = 20, 10 control samples and 10 irradiated 
samples) in order to quantify the staining of collagen (blue) and muscle, cytoplasm, and 
keratin (red). The readings for red and blue were averaged for each sample group to show 
a trend in the collagen content of the tissue samples. Student’s t-tests were then used to 
test for significant variation between the means. For the DMMB assay, Student’s t-tests 
were used to test for significance in GAG content of the media (n = 24) and tissue (n = 
27).  
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CHAPTER 5 
RESULTS AND DISCUSSION 
 
5.1  Histology Results 
5.1.1  Hematoxylin & Eosin 
  Staining of the sections 
with hematoxylin and eosin 
revealed some signs of apoptosis in 
the tissue sections from the control 
samples on days 3 and 5 (Figure 
5.1); however, there was clear 
morphological evidence of an 
increase in the occurrence of 
apoptosis in the irradiated samples 
on both days 3 and 5 (Figure 5.2 & 
5.3). Further examination of the 
irradiated samples using oil 
immersion microscopy further 
confirmed the morphological 
evidence, showing nuclear condensation and nuclear blebbing (Figure 5.4).  
Figure 5.1: (A) Control sample, day 3, 200x; (B) Control 
sample, day 5; H & E Stain, 400x (cells displaying 
apoptotic characteristics are circled) 
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Figure 5.2: Irradiated tissue section (5Gy), 3 days post-radiation; H & E Stain, 400x 
(cells demonstrating characteristics of apoptosis are circled) 
Figure 5.3: Irradiated tissue section (5Gy), 5 days post-radiation; H & E Stain, 400x 
(cells demonstrating characteristics of apoptosis are circled) 
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5.1.2  Masson’s Trichrome 
Qualitatively, there appear to be slight variations between the control and 
irradiated samples upon observation following staining. Using ImageJ, RGB 
measurements were taken to quantify the amounts of red (muscle, cytoplasm, and keratin) 
and blue (collagen) staining in each image. These mean of these measurements was taken 
to provide an average to allow comparisons.  
From visual observation of the non-irradiated control samples from day three 
(Figures 5.5 & 5.6), there appears to be an almost equal amount of red and blue dye. 
Using the RGB measurements from ImageJ, the overall blue-to-red ratio was calculated 
Figure 5.4: Examples of nuclear condensation (A) and nuclear blebbing (B); H & E 
Stain, 1000x (oil immersion), scale bars represent 2 µm. 
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to be 0.91, meaning that there was an almost equal distribution of the two dyes. By day 
five (Figures 5.7 & 5.8), the ratio of blue-to-red dropped to 0.54 for the control samples. 
From this data, we can see that the amount of cytoplasm, and/or keratin present surpasses 
the amount of collagen present between days 3 and 5. Qualitatively, the irradiated 
samples from day 3 show a distribution of red and blue similar to that of the control 
samples at day 3 (Figures 5.9 & 5.10). However, the blue-to-red ratio was calculated to 
be 0.85 (Table 5.1), which is less than the ratio of the control samples at day three. This 
means that there is slightly more cytoplasm, and/or keratin present in the irradiated 
samples than in the control samples after three days. Visual observation of the irradiated 
samples from day five appear to show a decrease in the amount of red staining (Figures 
5.11 & 5.12). Conversely, the calculation of the blue-to-red ratio came to 0.75 (Table 
5.1), meaning that there is still a greater amount of cytoplasm, and/or keratin than 
collagen present in the samples. A comparison between the differences in the blue-to-red 
ratios of the control and irradiated samples show that there is a greater difference between 
days three and five for the control samples than the irradiated ones (table 5.1). While 
there appeared to be difference, the quantified differences using ImageJ were not found to 
be statistically significant (p > 0.05). 
 
Table 5.1: Comparison of the amount of red and blue stain for all samples. 
 Red Blue Blue:Red Difference 
(D3-D5) 
0Gy D3 112.17 102.03 0.91 0.37 
0Gy D5 155.36 83.65 0.54   
5Gy D3 104.84 88.64 0.85 0.09 
5Gy D5 124.87 93.79 0.75   
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Figure 5.5: Examples of areas of control samples on day 3 which displayed more 
cytoplasm/keratin than collagen. Masson's Trichrome Stain, 40x, scale bars represent 750 µm 
 
 
 
Figure 5.6: Examples of areas of control samples on day 3 which displayed more 
collagen than cytoplasm/keratin; Masson's Trichrome Stain, 40x, scale bars 
represent 750 µm 
 
 61 
 
Figure 5.7: Examples of areas of control samples on day 5 which displayed more collagen than 
cytoplasm/keratin; Masson's Trichrome Stain, 40x, scale bars represent 750 µm 
 
 
Figure 5.8: Examples of areas of control samples on day 5 which displayed more cytoplasm/keratin 
than collagen; Masson's Trichrome Stain, 40x, scale bars represent 750 µm 
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Figure 5.9: Examples of areas of irradiated samples on day 3 that displayed more collagen than 
cytoplasm/keratin; Masson's Trichrome Stain, 40x, scale bars represent 750 µm 
 
 
 
 
 
 
 
 
 
Figure 5.10: Examples of areas of irradiated samples on day 3 that displayed more cytoplasm/keratin 
than collagen; Masson's Trichrome Stain, 40x, scale bars represent 750 µm 
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Figure 5.11: Examples of areas of irradiated samples on day 5 that displayed more collagen than 
cytoplasm/keratin; Masson's Trichrome Stain, 40x, scale bars represent 750 µm 
 
Figure 5.12: Examples of areas of irradiated samples on day 5 that displayed more cytoplasm/keratin 
than collagen; Masson's Trichrome Stain, 40x, scale bars represent 750 µm 
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5.1.3  Alizarin Red-S 
 There was evidence of an increase in Methyl Green uptake by the cells of the 
endotenon in the irradiated samples compared to the control samples (Figure 5.13). 
Furthermore, there were significantly more red spots indicative of calcium presence in 
the irradiated tissue sections on both day 5 when compared to the control samples from 
day 5 
Figure 5.13: Increased methyl green uptake was seen in the endotenon of irradiated samples (B) 
compared to control samples (A); Alizarin Red S Stain, 40x, scale bars represent 500 µm 
Figure 5.14: (A) Overall appearance of control tissue 5 days post-radiation, (B) Hardly any 
evidence of calcium was found in the control samples (red spot); Alizarin Red S Stain, 40x, 
scale bars represent 250 µm 
 65 
 Figure 5.15: Irradiated tissue samples showing evidence of calcium deposits (red 
spots); Alizarin Red S Stain, 100x, scale bars represent 250 µm. 
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5.1.4  Safranin-O Staining  
 Staining of the tissue sections following the Safranin-O Staining protocol 
confirmed the morphological evidence of increased apoptosis in the irradiated tissues. As 
seen in Figure 5.16, there were morphological indicators of apoptosis, such as nuclear 
and cytoplasm condensation and nuclear blebbing, dispersed throughout the irradiated 
Figure 5.18: Irradiated tissue sections (A&B) showing decreased 
PG expression (orange areas) compared to control samples (C&D). 
200x, scale bars represent 150 µm 
Figure 5.16: Irradiated tissue showed an increase in 
cellular apoptosis between day 3 (A&B) and day 5 
(C&D) as indicated by the arrows; Saffranin-O Stain, 
1000x (oil immersion), scale bars represent 3 µm 
Figure 5.17: Samples showing overall 
appearance of control tissue samples on 
day 5; Saffranin-O Stain, 400x, scale bars 
represent 25 µm 
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tendon tissue. In contrast, most of the control tissue samples were similar to Figure 5.17 
and didn’t display an increased expression of apoptosis, although some apoptotic bodies 
were seen, owing to apoptosis being a normal cellular event.  
Additionally, orange staining due to Safranin-O’s affinity for PGs was observed 
to assess change in PG content. Upon observation, there was a decrease in orange 
staining in the irradiated tissue sections compared to the control sections (Figure 5.18), 
representative of a decrease in the presence of PGs in the irradiated tissue and potentially 
indicative of an increase in PG concentration in the culture media.  
Additionally, orange staining due to Safranin-O’s affinity for PGs was observed 
to assess change in PG content. Upon observation, there was a decrease in orange 
staining in the irradiated tissue sections compared to the control sections (Figure 5.18), 
representative of a decrease in the presence of PGs in the irradiated tissue and potentially 
indicative of an increase in PG concentration in the culture media.  
 
5.2  In Situ Apoptosis Detection Results 
With the assay that was used, DNA fragmentation is indicated by brown staining 
using DAB. In the control samples from days three and five, very little brown staining 
was observed (Figure 5.19, 5.20, & 5.21). In the irradiated samples on day three, there 
was a slight increase in cells displaying brown staining compared to the control samples 
(Figure 5.22). On day five, the irradiated samples displayed a substantial increase in 
brown staining (Figure 5.23), which is consistent with the morphological data obtained 
through H&E and Safranin-O staining. Furthermore, apoptotic cells are said to display an 
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increased uptake of Methyl Green and this was seen in comparison of the control and 
irradiated samples from days three and five. 
Figure 5.19: Control tissue samples on day 3; (A) General appearance of tissue, (B) 
Some signs of apoptosis were seen as identified by the circle; TACS ® 2 TdT-DAB In 
Situ Apoptosis Detection, 400x, scale bars represent 10 µm 
Figure 5.20: Overall appearance of control samples on day 5; TACS ® 2 TdT-
DAB In Situ Apoptosis Detection, 400x, scale bars represent 10 µm 
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Figure 5.21: Control tissue samples on day 5, some signs of apoptosis were seen as indicated by 
the circles; TACS ® 2 TdT-DAB In Situ Apoptosis Detection, 400x, scale bars represent 10 µm 
Figure 5.22: Irradiated tissue 3 days post-irradiation, increased apoptosis was observed as indicated 
by the circles; TACS ® 2 TdT-DAB In Situ Apoptosis Detection, 400x, scale bars represent 10 µm 
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Figure 5.23: Irradiated tissue 5 days post-irradiation, increased apoptosis was observed 
as indicated by the circles; TACS ® 2 TdT-DAB In Situ Apoptosis Detection, 400x, scale 
bars represent 10 µm 
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5.3  Dimethylmethylene Blue Assay Results 
The normal curve generated from the varying concentrations of CS in standard 
solution appeared to saturate at CS concentrations greater than 125 µg/mL (Figure 5.24). 
Therefore, only data from the three lowest concentrations (0 – 125 µg/mL) was used to 
calculate the average standard regression line (Figure 5.25). 
Figure 5.24: Normal Curve of DMMB Assay 
 
Figure 5.25: Averages of the regression lines on these two graphs were used to calculate an average 
regression line for normalization of the assay data 
 72 
Three and five days following irradiation, the sGAG content in the irradiated 
tissue was noticeably lower than in the control tissue (Figure 5.26). This data coincides 
with the evidence introduced earlier from the Safranin-O staining showing less Safranin-
O staining of PGs in the irradiated versus control samples. Student’s t-test on the 
absorbency values averaged by tissue piece (n =27) showed statistical differences 
between the sGAG content in the irradiated tissue compared to the control samples on 
both days three and five (Figure 5.26).  
 
Over the first four days, the sGAG content in the culture media of the control and 
irradiated samples showed very similar results. However, on day five, there was a 
significantly greater difference between the media of the control and irradiated samples 
(Figure 5.27). Results from Student’s t-test on the absorbency readings from day five for 
both control and irradiated groups show significantly higher sGAG content in the culture 
Figure 5.26: sGAG content in the tissue at three and five days after irradiation normalized to the 
standard curve. Irradiated samples had significantly lower sGAG content when compared to control 
samples on both days (*, p < 0.01, n =27; **, p < 0.01, n =27). Error bars indicate ±standard 
deviation. 
** * 
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media of the irradiated sample than the culture media of the control samples (p < 0.05, n 
= 6) (Figure 5.28).  
 
Figure 5.27: Normalized sGAG content in the culture media over time (n = 24). Significantly higher 
sGAG was released into the media in irradiated samples when compared to control samples at Day 5 
(*, p < 0.01), Error bars indicate ±standard deviation. 
* 
* 
Figure 5.28: Normalized sGAG content in the culture media five days after 
irradiation. Culture media of the irradiated samples had significantly higher sGAG 
content when compared to control media on day 5 (*, p < 0.05, n =6). Error bars 
indicate ±standard deviation. 
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5.4  Discussion 
Studies have shown that radiation is known to cause genomic instability (Morgan 
et al., 1996), leading to cellular death (Cohen-Jonathan et al., 1999; Grasl-Kraupp et al., 
1995). Apoptotic cells are often seen following radiation in tissue sections. Results from 
the Hematoxylin and Eosin and Safranin-O staining methods revealed morphological data 
to support this. Results from the histological analysis suggest that there is an increase in 
the amount of cells undergoing apoptosis in irradiated tissue and this continues up to five 
days after irradiation. This conclusion was further supported by DNA fragment end 
labeling with DAB.  
Based on the results seen from staining the tissue sections with Alizarin Red S, 
there appears to be an increase in the presence of calcium salts as a result of the radiation 
exposure. This indicates that γ radiation induces a slight calcification in the tendon tissue. 
This event has been shown to cause negative changes in tendon mechanical properties. 
For example, in the case of Achilles tendinitis, damaged tendon fibers thicken and 
calcify, or harden, causing tendons to adapt a limited range of motion accompanied by 
pain and swelling. Additionally, with interstitial Achilles tendinitis, bone spurs tend to 
form (American Academy of Orthopaedic Surgeons, 2016). Furthermore, although 
mechanical testing was not executed during this study, evidence of potential negative 
impact of the radiation on the mechanical properties of the tendon became evident during 
preparation for histological testing. While using the microtome to slice the tissue 
sections, the tissue would pull apart a great deal and for the Alizarin Red S stain, had 
trouble maintaining contact with the charged slides.  
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Results from the DMMB assay revealed that, for the irradiated sample group, 
there was a significant increase in sGAG concentration in the culture media on day five. 
The results also showed that there were significantly less sGAGs expressed in the 
irradiated tissue than in the control tissues on both days three and five following 
irradiation. Because GAGs are the side chains upon which PGs rely, the decrease in 
sGAGs in the tissue implies a decrease in the amount of PGs as well. Studies have shown 
that tendons deficient in certain PGs also show a decrease in strength and stiffness 
(Zhang et al., 2006).  
Research has reported that tendons have a poor healing environment which is 
amplified by additional factors such as disease and prolonged immobilization (Lin et al., 
2004). Therefore, it is possible that the tendons investigated in this study were ideal 
situation cases. In the case of radiotherapy patients, the tendons surrounding the tumor 
(for example, in the case of a tissue sarcoma in the shoulder) would be affected by those 
previously mentioned additional factors.  
Research has also drawn a connection between oxidative changes caused by 
radiation and genomic instability in cells (Azzam et al., 2012). Furthermore, Sutherland 
et al. (2000) and Nikjoo et al. (1991) reported that approximately 60 ROS per nanogram 
of tissue are generated within less than a microsecond from a hit caused by 137-Cesium γ 
rays. It was reported that such a nuclear concentration of ROS could cause extensive 
oxidative injury in addition to causing modifications to normal biochemical reactions 
(Nikjoo, Goodhead, Charlton, & Paretzke, 1991; Sutherland, Bennett, Sidorkina, & 
Laval, 2000). The results from this study showed clear evidence of apoptosis and DNA 
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fragmentation. From this, we can conclude that potentially widespread oxidative changes 
are occurring in the irradiated tendons.  
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CHAPTER SIX 
CONCLUSIONS AND SUGGESTIONS FOR FUTURE WORK 
 
6.1  Conclusions 
A great deal of research has focused on the detrimental effects of ionizing 
radiation on biological tissues over the past few decades. However, while most of the 
studies involving ionizing radiation and tendinous tissues have dealt with high levels 
(kGy) of γ radiation, very few studies focus on the effects of low- and moderate-dose 
gamma irradiation on tendons. In this study, we sought to dose the tendons with 5 Gy of γ 
radiation in order to investigate the immediate effects of low dose radiation.  The lower 
dosing is important to understand what happens to the tendon tissue in the few days 
following a dose of radiation treatment.  
In the first phase of the study, histological aspects of the tendon were examined. 
Masson’s Trichrome revealed an increased expression of collagen while H&E and 
Safranin-O found an increased occurrence of apoptosis which was confirmed by DNA 
fragment end-labeling.  
The second phase of the study investigated the sGAG content of the tissue and 
culture media over time following irradiation exposure. Significant differences were seen 
between the control and irradiated groups in the sGAG content within the tissue (on days 
3 and 5) and in the culture media (on day 5).  
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6.2  Next Steps and Suggestions for Future Studies 
Due to the increase in collagen expression seen in the tissue sections stained with 
Masson’s Trichrome and Safranin-O, further work should be done to determine the 
specific collagen types present. Pataridis et al (2008) described a method for 
identification of collagen types I-V in rat tissue in tissues using HPLC-MS/MS (High 
Performance/Pressure Liquid Chromatography-Tandem Mass Spectrometry coupled to an 
IT mass spectrometer)(Grebe & Singh, 2011). The method used in Pararidis’ study is 
based on collagen fragmentation by cyanogen bromide following trypsin digestion. Then, 
analyses of resulting peptide mixtures, or peptide maps, were performed using HPLC-
MS/MS. Peptides specific to each collagen type were selected; the peptides selected for 
this study are found in human, bovine, & rat collagens, allowing this to be applied to the 
tissues of other species. Pataridis also cites the most common method for determining 
total collagen is based on quantitation of hydroxyproline, which accounts for 
approximately 10% of the collagen molecule (Stagemann & Stalder, 1967; Verch, 
Wallach, & Peabody, 1979; Pødenphant, Larsen, Christiansen, 1984). 
We developed a method for sample mounting and testing (Appendix K). 
However, due to material and time constraints, mechanical testing was not able to be 
carried out on our samples. Based on the morphological data from the tissue sections 
stained with Alizarin Red S, mechanical testing should reveal interesting results. Calcium 
deposits in tendons, as well as other connective tissues, have shown a negative 
correlation with biomechanical properties (Article from AAOS, find others). 
Additionally, Fideler et al. have reported a dose-dependent effect of irradiation on all 
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biomechanical parameters investigated in their study. The results indicated that there was 
a statistically significant (p < 0.01) reduction in maximum force, strain energy, modulus, 
and maximum stress of the human bone-patellar tendon-bone allografts after exposure to 
γ irradiation. Research reported by Danielson et al (1997) and Zhang et al (2006) describe 
a close correlation between the presence of decorin, a PG, and mechanical properties of 
the tissue. In our study, data obtained from the DMMB assay showed changes in the 
GAG content of the tissue and culture media of irradiated samples. Therefore, 
considering the results from our study showing evidence of calcium staining in irradiated 
tissues as well as the reduction in the tissue GAG content, it seems likely that irradiation 
at the doses used in this study could lead to a reduction of several of the tendon’s 
mechanical properties. 
Our results with the Safranin-O and DMMB assays show that 5Gy of γ radiation 
induces changes in the content of PGs (i.e. aggrecan) and sGAGs in the tendon tissue. 
Taking this into account, further experiments should be performed in order to measure 
the rate of PG deposition and turnover in tendinous tissue. Waggett et al (2004) described 
such an experiment, which they conducted on bovine digital flexor tendon explants. The 
explants were precultured, then cultured for an additional four days in two experimental 
groups. One group was given marimastat (0-2 µM) or acitonin (0-200 µM). Following the 
second culture, the explants were pulse-chase labelled with sulfate (35S). The rate of 
turnover of 35S-labelled PGs from the tendon matrix could then be calculated from the 
amount of 35S-labelled macromolecules seen in the medium each day, and in the matrix 
of the explants at the end of the experiment’s allotted time frame.  
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Along the same lines, an investigation into the types of PGs experiencing 
fluctuations in turnover rate is suggested. Zhang and colleagues published a similar study 
in 2006 in which they were able to indicate the presence or deficiency of the PGs decorin 
and biglycan in the tendons of mice. The results from the tissue samples stained with 
Safranin-O showed a decreased presence of PGs in the irradiated tissue, further 
confirming a change in PG turnover as a result of gamma radiation. 
Future research on this topic should involve extending the length of the study well 
past five days following radiation exposure. Based on the results from the historical 
analyses and from the DNA fragmentation end-labeling assay, the length of the increase 
in apoptotic bodies present in the tendon tissue should be examined. Additionally, based 
on the data gathered from the DMMB assay, extending the length of the study would 
allow investigators to determine if there is a further increase in the sGAG content of the 
culture media and if the decreased expression in the tissue returns to levels similar to the 
control tendon over time. Extending the study duration could help to determine whether 
the changes in tendon matrix observed in this study were short-term effects and can be 
reversed or whether they persist over longer periods. In addition, further studies into 
other clinically relevant dosage schemes and other types of radiation on tendinous tissue 
should be executed. 
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APPENDIX A 
 
Anti-Microbial Wash Protocol 
 
Materials: 
PBS -------- 500 mL 
5 mM Benzamidine-hydrocholoride -------- 2.5 mL 
2 mM phenylsulfonyl fluoride -------- 0.06 mL 
Protease inhibitor cocktail -------- 1 mL 
5 mM EDTA -------- 0.7306 g 
5 mM N-ethyhnaleimide -------- 0.3128 g 
 
Directions: 
Place tendon sections in sample cups according to testing group (control & 
irradiated). Add enough anti-microbial wash to fully submerge all samples. Leave at 
room temperature for 20 minutes. After 20 minutes, remove samples from cups and 
wash with culture media (Appendix B).  
 
Protocol adapted from: 
Fukuta, S., Oyama, M., Kavalkovich, K., Fu, F. H., & Niyibizi, C. (1998). 
Identification of types II, IX and X collagens at the insertion site of the bovine 
achilles tendon. Matrix Biology, 17, 65-73. 
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APPENDIX B 
 
Culture Media for Tendon Tissue Protocol 
 
Materials: 
1. Low glucose Dulbecco’s Modified Eagles Medium (add 435 mL to make 500 mL 
media)   
2. Fetal Bovine Serum: 10% v/v (50 mL/500 mL media)   
3. Nonessential Amino Acids: 1% v/v (5 mL/500 mL media)   
 
Directions: 
1. Bring all ingredients to room temperature in warming bath. 
2. Add FBS and Nonessential AA to DMEM. 
3. Mix by inversion and store at 20°C (fridge temp). 
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APPENDIX C 
 
Hematoxylin & Eosin (H&E) Staining Protocol 
 
Fixation: Any 
Technique: Paraffin or frozen 
 
SOLUTIONS: Mix thoroughly before dispensing. 
 
Hematoxylin I (Richard-Allan, Order # 7221)  
Clarifier I (Richard-Allan, Order # 7401) 
Bluing Reagent (Richard-Allan, Order # 7301) 
Eosin-Y with Phloxine (Richard-Allan, Order # 71304) 
 
STAINING PROCEDURE: 
1. Xylenes  10 dips 
2. Xylenes  5 min 
3. 100% ETOH  10 dips 
4. 100% ETOH  1 min 
5. 95% ETOH  10 dips 
6. 95% ETOH  1 min 
7. Tap Water  Till “sheeting” action occurs 
8. Distilled Water  1 min 
9. Hematoxylin  5 – 10 min (check with microscope) 
10. Tap Water  Till clear 
11. Clarifier  3 – 6 dips 
12. Tap Water  Till “sheeting” action occurs 
13. Bluing Reagent 1 min 
14. Tap Water  1 min  
15. 95% ETOH  10 dips 
16. Eosin   30 – 45 sec 
17. 95% ETOH  10 dips 
18. 95% ETOH  10 dips 
19. 100% ETOH  10 dips 
20. 100% ETOH  1 min 
21. 100% ETOH  3 min 
22. Xylenes  10 dips 
23. Xylenes  5 min 
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Let slides remain in last container until a coverslip is applied. 
 
RESULTS: 
Nuclei-------------------------------------------------------blue 
Erythrocytes and eosinophilic granules----------------bright pink to red 
Cytoplasm and other tissue elements-------------------various shades of pink 
 
Source: Richard-Allan ScientificTM 
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APPENDIX D 
 
Masson’s Trichrome Protocol 
 
Description: This method is used for the detection of collagen fibers in tissues such as 
skin, heart, etc. on formalin-fixed, paraffin-embedded sections, and may be used for 
frozen sections as well. The collagen fibers will be stained blue and the nuclei will be 
stained black and the background is stained red. 
 
Fixation: 10% formalin or Bouin's solution 
Section: paraffin sections at 5 µm 
 
Solutions and Reagents: 
 
Bouin's Solution: 
Picric acid (saturated) ------------------- 75 mL 
Formaldehyde (37-40%) ------------------ 25 mL 
Glacial acetic acid ------------------------- 5 mL 
Mix well. This solution will improve Masson Trichrome staining quality. 
 
Weigert's Iron Hematoxylin Solution: 
 
Stock Solution A: 
Hematoxylin ----------------------------- 1 g 
95% Alcohol ----------------------------- 100 mL 
 
Stock Solution B: 
29% Ferric chloride in water --------- 4 mL 
Distilled water ------------------------ 95 mL 
Hydrochloric acid, concentrated ---- 1 mL 
 
Weigert's Iron Hematoxylin Working Solution: 
Mix equal parts of stock solution A and B. This working solution is stable for 3 
months (no good after 4 months) 
 
Biebrich Scarlet-Acid Fuchsin Solution: 
Biebrich scarlet, 1% aqueous --------- 90 mL 
Acid fuchsin, 1% aqueous --------------10 mL 
Acetic acid, glacial --------------------- 1 mL 
 
Phosphomolybdic-Phosphotungstic Acid Solution: 
5% Phosphomolybdic acid ------------- 25 mL 
5% Phosphotungstic acid -------------- 25 mL 
 
 90 
Aniline Blue Solution: 
Aniline blue ------------------------------- 2.5 g 
Acetic acide, glacial --------------------- 2 mL 
Distilled water --------------------------- 100 mL 
  
1% Acetic Acid Solution: 
Acetic acid, glacial ----------------------- 1 mL 
Distilled water ---------------------------- 99 mL 
 
Procedure: 
  
1.   Deparaffinize and rehydrate through 100% alcohol, 95% alcohol 70% alcohol. 
2.   Wash in distilled water. 
3.   For Formalin fixed tissue, re-fix in Bouin's solution for 1 hour at 56 C to 
improve staining quality although this step is not absolutely necessary. 
4.   Rinse running tap water for 5-10 minutes to remove the yellow color. 
3.   Stain in Weigert's iron hematoxylin working solution for 10 minutes. 
4.   Rinse in running warm tap water for 10 minutes.  
5.   Wash in distilled water. 
6.   Stain in Biebrich scarlet-acid fuchsin solution for 10-15 minutes. Solution can be 
saved for future use.  
7.   Wash in distilled water. 
8.   Differentiate in phosphomolybdic-phosphotungstic acid solution for 10-15 
minutes or until collagen is not red. 
9.   Transfer sections directly (without rinse) to aniline blue solution and stain for 5-
10 minutes. Rinse briefly in distilled water and differentiate in 1% acetic acid 
solution for 2-5 minutes. 
10. Wash in distilled water. 
11. Dehydrate very quickly through 95% ethyl alcohol, absolute ethyl alcohol (these 
step will wipe off Biebrich scarlet-acid fuchsin staining) and clear in xylene. 
12. Mount with resinous mounting medium. 
 
Results: 
Collagen ---------------------------------------- blue 
Nuclei ------------------------------------------- black 
Muscle, cytoplasm, keratin ------------------- red   
 
Positive Controls: 
Skin, lung, stomach, intestine. 
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APPENDIX E 
 
Saffranin-O Staining Protocol 
 
Description: This method is used for the detection of cartilage, mucin, and mast cell 
granules on formalin-fixed, paraffin-embedded tissue sections, and may be used for 
frozen sections as well. The cartilage and mucin will be stained orange to red, and the 
nuclei will be stained black. The background is stained bluish green. 
  
Fixation: Formalin fixed, paraffin embedded sections. 
 
Solutions and Reagents: 
 
Weigert's Iron Hematoxylin Solution: 
Stock Solution A: 
Hematoxylin ----------------------------- 1 g 
95% Alcohol ----------------------------- 100 mL 
Stock Solution B: 
      29% Ferric chloride in water ----------- 4 mL 
      Distilled water -------------------------- 95 mL 
Hydrochloric acid, concentrated ---- 1mL 
 
Weigert's Iron Hematoxylin Working Solution: 
Mix equal parts of stock solution A and B. This working solution is stable for about 4 
weeks. 
   
0.05% Fast Green (FCF) Solution: 
      Fast green, FCF, C.I. 42053 ------------- 0.5 g 
      Distilled water ---------------------------- 1000 mL 
  
1% Acetic Acid Solution: 
      Acetic acid, glacial ------------------------- 1 mL 
      Distilled water ------------------------------ 99 mL 
  
0.1% Safranin O Solution: 
      Safranin O, C.I. 50240 -------------------- 0.1 g 
      Distilled water ----------------------------- 100 mL 
  
Procedure: 
1.   Deparaffinize and hydrate slides to distilled water. 
2.   Stain with Weigert’s iron hematoxylin working solution for 10 minutes. 
3.   Wash in running tap water for 10 minutes. 
4.   Stain with fast green (FCF) solution for 5 minutes. 
5.   Rinse quickly with 1% acetic acid solution for no more than 10 –15 seconds. 
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6.   Stain in 0.1% safranin O solution for 5 minutes. 
7.   Dehydrate and clear with 95% ethyl alcohol, absolute ethyl alcohol, and xylene, 
using 2 changes each, 2 minutes each. 
8.   Mount using resinous medium. 
  
Results: 
Nuclei ---------------------------------------------- black 
Cytoplasm ----------------------------------------- bluish green 
Cartilage, mucin, mast cell granules ----------- orange to red 
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APPENDIX F 
 
Alizarin Red Staining Protocol 
 
I. Stains 
A. 1% Alizarin Red S Solution (Stable for ~1 Month) 
1. Add 1 g alizarin red S to 100 ml distilled water 
2. Add 10 ml 0.1% ammonium hydroxide to alizarin red 
solution with constant stirring. Resulting pH of stain should 
be 6.36-6.40. Make ammonium hydroxide solution by adding 
0.1 ml ammonium hydroxide (C.P. 28%) to 100 ml distilled 
water. 
 
B. 1% Light Green Solution 
1. Add 1 g light green, SF yellowish to 100 ml distilled water. 
2. Add 1 ml glacial acetic acid 
 
II. Staining Procedure 
A. Fix cells in 2% FA, 10 minutes, RT 
B. Rinse with PBS several times 
C. Add alizarin red S solution for 5-10 minutes 
D. Remove excess stain with 5-6 changes of distilled water. 
E. Counterstain in light green solution for ~8-10 seconds. 
F. Immediately rinse off excess light green solution. 
G. Keep in water. 
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APPENDIX G 
 
TACS ® 2 TdT-DAB In Situ Apoptosis Detection Kit Protocol 
(Trevigen Inc., Gaithersburg, MD; Catalog# 4810-30-K) 
 
I. Materials Supplied: 
Component: Quantity: Storage: 
Proteinase K Solution  50 µL -20 °C 
CytoninTM 6 mL 4 °C 
10X TdT Labeling Buffer 100 mL  4 °C 
10X TdT Stop Buffer 100 mL 4 °C 
TdT dNTP Mix 35 µL -20 °C 
TdT Enzyme 35 µL -20 °C 
Strep-HRP 30 µL 4 °C 
DAB Solution 3.75 mL - 20 °C 
DAB Enhancer 1 mL - 20 °C 
50X Co2+ 30 µL - 20 °C 
50X Mg2+ 30 µL - 20 °C 
50X Mn2+ 50 µL - 20 °C 
TACS-NucleaseTM 15 µL - 20 °C 
TACS-Nuclease Buffer  1.5 mL 4 ° C 
1% Methyl Green 50 mL RT 
II. Materials and Equipment needed but not supplied: 
Equipment 
1. 1 - 20 µL, 20 - 200 µL, and 200 - 1000 µL pipettors 
2. 37°C Incubator 
3. 50 and 500 mL Graduated cylinders 
4. 2 Coplin jars 
5. -20°C and 4°C storage 
6. Ice bucket 
7. Standard light microscope 
8. Cryostat or microtome 
9. Humidity chamber 
10. 57 °C incubator or slide warmer 
11. Pipette helper 
12. Timer 
Reagents 
1. Apoptosis GradeTM Water 
2. 10X PBS 
3. 37% Formaldehyde 
4. Xylenes 
5. 30% Hydrogen peroxide 
6. 95% and 100% Ethanol (or denatured alcohol) 
7. Methanol 
8. Butanol 
9. Mounting medium or alternative mounting solution e.g. Permount 
Disposables 
1. Treated Glass Microscope Slides (or alternative support) 
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2. 50 ml tubes 
3. 1 - 200 µL and 200 - 1000 µL pipette tips 
4. microcentrifuge tubes 
5. 1.5 and 10 ml serological pipets 
6. gloves 
7. Hydrophobic Coverslips (optional) 
8. Glass coverslips 
 
III. Reagent Preparation: 
Note: Reagents labeled with an asterisk (*) should be prepared immediately before use 
(This is an abbreviated list, full reagent preparation can be found in the product manual on the Trevigen 
website:  https://www.trevigen.com/docs/protocol_4810-30-K.pdf?guid=1455824221)  
 
1. * 3.7% Buffered Formaldehyde 
50 mL of freshly prepared fixative is used to process 1 to 10 samples. To prepare, 
add: 
37% Formaldehyde 5 mL 
10X PBS  5 mL 
ddH2O 40 mL 
Wear gloves and exercise caution when handling formaldehyde solutions. 
2. * Proteinase K Solution 
Use 50 µL of Proteinase K Solution per sample. Store on ice. Thaw provided 
Proteinase K at room temperature, then place on ice. To prepare, add: 
 2 samples 10 samples n samples 
Deionized water 100 µL 500 µL n x 50 µL 
Proteinase K 2 µL 10 µL n x 1 µL 
3. * Quenching Solution 
Use 50 mL of Quenching Solution to process 1 to 10 samples. To prepare, add: 
Methanol 45 mL 
30% Hydrogen Peroxide 5 mL 
4. 1X TdT Labeling Buffer 
Dilute the 10X TdT Labeling Buffer (Cat# 4810-30-02) to 1X using distilled 
water. Leave at room temperature until use. Use 50 mL of 1X Labeling Buffer to 
process 1 to 10 samples. Remove an aliquot of 50 µL per sample or preparing the 
Labeling Reaction Mix (see below) and place on ice. 
5. * Labeling Reaction Mix 
Thaw TdT dNTP Mix at room temperature, then place on ice. To maintain 
optimal enzyme activity, remove the TdT Enzyme tube from freezer only long 
enough to pipette the required volume. Alternatively, place the TdT Enzyme in a 
-20 °C freezer block. Prepare the Labeling Reaction Mix just before use and keep 
the prepared reaction mix on ice. Prepare 50 µL per sample in the sequence given 
below:  
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 2 samples 10 samples n samples 
TdT dNTP Mix 2 µL 10 µL n x 1 µL 
TdT Enzyme 2 µL 10 µL n x 1 µL 
50X Cation Stock 2 µL 10 µL n x 1 µL 
1X TdT Labeling Buffer 100 µL 500 µL n x 50 µL 
6. 1X TdT Stop Buffer 
Dilute the 10X TdT Stop buffer to 1X using distilled water. Leave at room 
temperature until use. Use 50 mL of 1X TdT Stop Buffer to process 1 to 10 
samples. 
7. * Strep-HRP Solution 
Use 50 µL of Strep-HRP Solution per sample. Store at room temperature until 
use. To prepare, add: 
 2 samples 10 samples n samples 
1X PBS 100 µL 500 µL n x 50 µL 
Strep-HRP 2 µL 10 µL n x 1 µL 
8. * DAB Solution 
Thaw DAB at 37 °C for 30 min. If not using the full bottle, store the remaining 
stock solution back at -20°C. It is not recommended to freeze thaw DAB stock 
solution more than three times. If required, aliquot in smaller volume and store at 
-20°C protected from light. To prepare, add:  
1X PBS 50 mL 
DAB 250 µL 
DAB Enhancer 0 to 50 µL 
30% Hydrogen Peroxide  50 µL 
Use only fresh 30% hydrogen peroxide. It is recommended that 6 mL aliquots of 
fresh 30% hydrogen peroxide are made and stored at 4 °C. For each labeling 
procedure use a fresh 30% hydrogen peroxide aliquot then discard any remaining 
solution.  
Note: Do not place the DAB (Cat# 4800-30-07) on ice after thawing, otherwise 
the DAB will precipitate. Prepare DAB Solution no more than 30 minutes before 
use. Use 50 mL of DAB Solution to process 1 to 10 samples. DAB Enhancer 
may be used to intensify and darken DAB staining; the concentration must be 
optimized experimentally. 
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IV. Sample preparation and fixation:
Figure 3: Tissue sample preparation flow chart, taken from TACS(R) TdT-DAB In Situ 
Apoptosis Detection Kit Protocol 
** Deparaffinization: Sections prepared from paraffin blocks require removal of the 
paraffin prior to the labeling reaction. 
Method: 
1. Warm slides to 57 °C for 5 minutes.
2. Immerse sections in 2 changes of xylenes, 5 minutes each.
3. Immerse sections in 100%, 95% then 70% ethanol, 5 minutes each.
4. Wash 2 times in 1X PBS, 5 minutes each.
5. Proceed to Labeling Procedure below.
V. Labeling Procedure for Immobilized, Fixed, and Rehydrated Samples in 1X PBS
Step Instructions Notes 
1 
Place samples in 1X PBS for 10 
minutes at room temperature after 
rehydration in ethanols. Carefully 
dry glass slide around sample. 
DO NOT allow sample to DRY at 
any stage prior to completion of 
protocol. 
2 
Cover sample with 50 µL of 
Proteinase K Solution and incubate 
15 to 30 minutes at room 
temperature, or cover sample with 
50 µL of CytoninTM and incubate for 
30-120 minutes at room temperature
or 4 °C. If necessary, use Cover
Slips.
CytoninTM is recommended for 
frozen sections and when protease 
treatment will destroy antigens of 
interest in double labeling 
experiments. Time of Proteinase K 
treatment will vary between cell type. 
Start at 15 minutes and increase if no 
labeling occurs. 
3 Wash 2 times in deionized water, 2 minutes each. 
4 
Immerse slides in Quenching 
Solution for 5 minutes at room 
temperature. 
Do not leave longer than 5 minutes 
since hydrogen peroxide can damage 
DNA. 
5 Wash samples in 1X PBS for 1 minute at room temperature. 
** 
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6 Immerse slides in 1X TdT Labeling Buffer for 5 minutes. 
7 
Cover sample with 50 µL of 
Labeling Reaction Mix and incubate 
at 37 °C for 1 hour in a humidity 
chamber. If necessary, use 
Hydrophobic Coverslips. 
8 
Immerse samples in 1X TdT Stop 
Buffer for 5 minutes at room 
temperature to stop labeling 
reaction. 
9 
Wash samples 2 times in deionized 
water for 5 minutes each at room 
temperature. 
This step removes unbound 
conjugate. 
10 
Cover sample with 50 µl of Strep-
HRP solution and incubate for 10 
minutes at 37 °C. If necessary, use 
hydrophobic coverslips. 
Follow color development under the 
microscope to determine time of 
incubation. 
11 Wash samples 2 times in 1X PBS for 2 minutes each. 
12 Immerse samples in DAB solution for 2 to 7 minutes. 
Use caution when handling DAB 
solution. 
13 Wash samples in several changes of deionized water for 2 minutes each. 
14 Proceed to Counterstaining and Preparation for Viewing. 
VI. Counterstaining and Preparation for Viewing
Cells and tissues may be counterstained with Methyl Green. Glass coverslips can be 
held in fine tipped forceps and dipped individually into the stains and ethanols. Spot 
only 25 µl mounting medium onto a clean glass slide and mount the coverslip, cell 
side down, onto the slide. If a plastic support was used for cell culture, do not pass 
through xylenes.  
Method A (for most cells and tissues) 
1. Immerse samples in deionized water for 2 minutes.
2. Immerse samples for 5 seconds to 5 minutes in Methyl Green.
3. Wash slides sequentially by dipping ten times each in:
a. Deionized water
b. 70% ethanol, 2 changes
c. 95% ethanol, 2 changes
d. 100% ethanol, 2 changes
e. Xylenes, 2 changes
4. Wipe off excess xylenes from the back of the slide and lay slide flat.
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5. Place one drop, about 50 µL, of mounting medium from a 100 µL pipet onto 
sample. 
6. Lower glass coverslip onto sample and apply gentle even pressure to expel 
air bubbles.  
7. Leave slides flat overnight to allow mounting medium to harden 
8. Store slides in the dark. 
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APPENDIX H 
 
Collagenase Tissue Digestion for Porcine Tendon 
 
 
Collagenase solution (sterile filtered):  20 mg/ml Bovine Serum Albumin (Fraction V) 
in DMEM (1 g/L glucose) + 1% Am/AB + 2mg / ml collagenase type I (Worthington – 
MX1D12644: 249 U/mg)  
 
Directions: 
1. In an aseptic cell culture hood, rinse tendon tissue once in 20 ml of sterile 1x PBS 
to remove any excess blood. 
2. Cut tendons into approximately 3 x 3 mm pieces/cubes with sterile scalpel blades 
in a sterile petri dish. 
3. Weigh each cube of tendon separately and place individually in wells of a 24-well 
plate.  
4. Add 2 mL of sterile filtered collagenase solution to each well containing a tendon 
sample and incubate at 37°C overnight (> 15 hours) at 86 RPM (VWR Incubating 
Orbital Shaker). 
5. Stop collagenase by adding FBS (10% of volume used in step 5 so about 200 µL). 
 
Source: Mazzocca, A. D., Chowaniec, D., McCarthy, M. B., Beitzel, K., Cote, M. P., 
McKinnon, W., & Arciero, R. (2012). In vitro changes in human tenocyte cultures 
obtained from proximal biceps tendon: Multiple passages result in changes in routine cell 
markers. Knee Surgery, Sports Traumatology, Arthroscopy, 20(9), 1666-72.  
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APPENDIX I 
Dimethylmethylene Blue (DMMB) Assay Protocol 
Materials and Reagents 
1. Dimethylmethylene blue (DMMB) (Sigma-Aldrich, catalog number: 341088)
2. NaCl
3. Glycine (Sigma-Aldrich, catalog number: 410225)
4. Glacial Acetic acid (Sigma-Aldrich, catalog number: S7653)
5. Tris-Base (Merck KGaA, catalog number: 648310)
6. Bovine chondroitin 4-sulfate as standard (Sigma-Aldrich, catalog number: C9819)
7. DMMB reagent (see Recipes)
Equipment 
1. Plate mixer (VWR International, catalog number: 89202-332)
2. Cover adhesive (R&D Systems, catalog number: DY992)
3. Microplate reader with 525 nm (BioTek Instruments, catalog number: 11-120-
531)
4. 96 well microplate spectrophotometer with 525 nm filter set (Thermo Fisher
Scientific, catalog number: 51119200)
5. Microplate shaker (VWR International, catalog number: 97043-608)
Procedure 
1. Prepare DMMB reagent and paper filter using Whattman® 3MM. The pH of this
solution is around 3.0. To prepare 1 L dye solution, dissolve 16 mg DMMB in 1 L
water containing 3.04 g glycine, 1.6 g NaCl and 95 ml of 0.1 M Acetic Acid.
2. Prepare standard solution of chondroitin 4 sulfate (500 µg/ml in H2O). Prepare
standard curve as stated in the table bellow.
3. Pipet the standard stock solution and complete the volume to 20 µl with H2O into
the 96 well microplate.
4. Pipet 20 µl of each sample into the microplate.
5. Add 200 µl of DMMB to each sample and shake the plate of a plate shaker for 5
sec.
6. Read the absorbance using a plate reader at 525 nm immediately.
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Notes 
1. DMMB assay can normally be performed on samples with high detergent and salt 
concentrations; however the standard curve should be prepared in the same 
solution. 
2. Avoid to performing the assay on samples in high albumin or serum 
concentrations, which may interfere with the assay (Warren, 2000). 
3. Some groups have reported the interference of DNA in the DMMB assay; 
however, decreasing the pH to approximately 3 and increasing salt concentrations 
makes the interference of DNA negligible. 
4. DMMB requires the length of glycosaminoglycan chain be over a tetrasaccharide. 
5. DMMB reacts with the sulfate group of the GAG chain and therefore will not 
work with unsulfated GAGs such as hyaluronic acid. 
6. Further information can be acquired by utilizing the carbazole reaction (sensitivity 
from 1 to 20 µg) to assay the carboxyl groups of the uronic acid for heparin 
sulfate, chondroitin sulfate and dermatan sulfate and/or anthrone reaction to assay 
the hexose group for keratan sulfate (Mort and Roughley, 2007). 
7. The DMMB can also be very efficient when performing chromatography to 
rapidly assay for fractions containing GAGs (Burton-Wurster et al., 2003). 
8. The DMMB-GAG complex that is formed results in the immediate formation of 
turbidity, however this complex starts to precipitate within 10 min, therefore the 
absorbance measurement should be performed immediately. 
 
Recipes 
1. DMMB reagent 
Dissolve 16 mg DMMB, 3.04 g glycine, 1.6 g NaCl and 95 ml of 0.1 M acetic 
acid and complete the volume to 1 L 
Filter (0.45 µm) 
Protect from light 
Do not use if precipitate is present in the solution 
 
 
Source: http://www.bio-protocol.org/e1236 
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APPENDIX J 
Schematic for Mechanical Testing 
 
The following instructions are adapted from Separation of Bovine Achilles Tendon Ends 
Repaired with Krackow and Modified Mason-Allen Suture Technique Under Cyclic 
Loading: A Biomechanical Study (J.T. Kim et al.) and are for the mechanical testing of a 
tendon using a servohydraulic testing machine. 
 
1. The distal end (osseous junction) of 
the specimen was cemented and fixed 
securely into a round plastic pot. 
2. A nylon strap was then sewn to the 
proximal end (muscular junction) of 
the specimen using nylon suture. 
3. The specimen was positioned into a 
servohydraulic testing machine (Inst-
ron Model #8874) base where the 
plastic pot was anchored to the lower 
testing frame platform  
4. The nylon strap was then secured to 
the actuator of the test frame using a 
servohydraulic clamp.  Dry ice was 
fixed to the nylon strap to freeze the 
proximal portion of the tendon and 
adhere it to the strap material.  
 
 
